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E-mail address: alessandro.prinetti@unimi.it (A. PrCaveolin-1, and probably also -2 and -3, can organize multimolecular membrane complexes
involved in transmembrane trafﬁc, cell adhesion and signal transduction. In this review, we discuss
on the importance of caveolin membrane environment in regulating the architecture and function
of such complexes, with a special emphasis on the role of sphingolipids.
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The identiﬁcation of caveolin-1 as the main structural compo-
nent of caveolae, together with the ﬁnding that caveolin-1 might
serve as a molecular organizer for membrane multiprotein com-
plexes involved in cellular trafﬁc, endo- and transcytosis, cell adhe-
sion and signal transduction prompted a new impulse in the
research on these intracellular organelles. Almost at the same time,
the concept of lipid rafts was born, and the observation that cave-
olae and lipid rafts share one striking biochemical property, the
insolubility in non-ionic detergent under speciﬁc experimental
conditions, led to the claim that caveolae represent a specialized
sphingolipid- and cholesterol-enriched membrane domain stabi-
lized and organized by caveolin. Several recent and comprehensive
reviews covered all aspects of the research on caveolae, caveolins
and lipid rafts [1–13]. The purpose of this review is to focus on data
in the literature that underscore the existence of different mem-
brane environments enriched in caveolin, keeping in mind the fol-
lowing points: (1) caveolin-rich membrane domains do not always
represent caveolae; (2) the relationship between caveolae, caveo-
lin-rich domains and lipid rafts, conceived as sphingolipid-rich
membrane domains, is very complex, and sphingolipid–caveolinchemical Societies. Published by E
ptor; GPI, glycosylphosphati-
tein associated with glyco-
tor receptor; RTK, receptor
inetti).interaction can probably occur in caveolae, in lipid rafts as well
in other membrane areas; (3) sphingolipids, and in particular
glycosphingolipids, have a high potential for regulating caveolin-
1-mediated biological events, such as the regulation in terms of
activity and cell surface concentration of membrane receptors.
Our conclusion, based on the pieces of evidence discussed in this
review, is that caveolin is playing its undoubtedly important multi-
ple biological roles in heterogeneous membrane microenviron-
ments, whose structure and dynamics are still largely to unveil.
2. Caveolae and caveolins
Over 50 years ago, Palade discovered invaginated structures
with a 50–100 nm diameter in the heart endothelium, that, due
to their size, peculiar morphology and lack of an evident coat, were
distinct from other known plasma membrane-associated vesicles,
and named them plasmalemmal vesicles [14]. Shortly after, Yam-
ada identiﬁed the same structures in the gall bladder epithelium,
and termed them caveolae intracellulare, due to their appearance
as ‘‘little caves” (deep omega-shaped or ﬂask-shaped invaginations
with a narrow neck and a round lumen) [15]. The adjective was
quickly forgotten, and up to today morphologically distinguishable
caveolae have been identiﬁed in many cell types, but not in all,
being particularly abundant in endothelial cells, adipocytes,
smooth muscle cells and ﬁbroblasts, and probably absent in lym-
phocytes and mature neurons. Moreover their number, density
and morphology can greatly vary depending on the speciﬁc cell
type and the physiological status of the cell. Morphological studieslsevier B.V. All rights reserved.
Table 1
Caveolae- and caveolin-dependent biological events.
Caveolae Caveolin
 Transcytosis
 Endocytosis
 Pathogen entry
 Uptake of cholesterol esters
 Reverse cholesterol transport
 Uptake of cholesterol esters
 Signaling platform
 Intracellular cholesterol balance
 Molecular organizer (caveolin scaffold-
ing domain)
Interaction with:
G protein coupled receptors
Growth factor receptors
G protein subunits
Non-receptor tyrosine kinases
Small GTPases
eNOS
Inhibition of downstream targets:
c-Src
eNOS
H-Ras
MAP kinases
 Tumor suppression
 Formation of cytosolic complexes
with:MicrotubulesHeat Shock Proteins
Table 2
Cell regulation by caveolin outside caveolae.
cAMP production
Cell adhesion
Injury-induced neuronal plasticity
T cell activation
Leukocyte diapedoxidative stressesis
Bilary secretion in the liver
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ﬁrst clues about their possible biological functions, e.g. suggesting
that caveolae might be involved in two-way communication and
exchange of molecules between the cell and the extracellular envi-
ronment (endocytosis and transcytosis), and that they are part of a
complex vesicular system shuttling between the plasma mem-
brane and intracellular sites [16]. On the other hand, the morpho-
logical deﬁnition became more faded along the years, since it
became clear that shallower caveolae or caveolae with a more
complex organization can exist. Forty years after the discovery of
caveolae, they were redeﬁned on a biochemical and molecular ba-
sis with the discovery of caveolins. Originally identiﬁed as one of
the main tyrosine phosphorylated substrates in v-src-transformed
ﬁbroblasts [17], caveolin gained its name with the demonstration
of its presence in the striated coat that decorates the cytoplasmic
surface of caveolae [18]. Its sequence was found to be identical
to that of VIP21 (vesicular integral membrane protein of 21 kDa),
a protein identiﬁed as a component of transport vesicles derived
from the trans-Golgi network [19]. Caveolins are a family of 21–
24 kDa integral membrane proteins, and are the main structural
protein component of caveolae [20]. VIP21–caveolin, now caveo-
lin-1 (two other members of the family, caveolin-2 and -3 were
subsequently identiﬁed [20]), has a hydrophobic putative mem-
brane-spanning sequence and three palmitoylation sites at the C-
terminal domain, that contribute in stabilizing the characteristic
hairpin loop conformation of the protein associated with the mem-
brane. Caveolins form high-mass homo- or hetero-oligomeric com-
plexes, that generate the ﬁlamentous coating of caveolae. The
emphasis on caveolins however was posed by the observation that
caveolin oligomers can serve as a scaffold for several caveolin-
interacting proteins (including H-Ras, c-Src, heterotrimeric G-pro-
teins and growth factor receptors, that can thus be concentrated
within caveolae membranes. This ﬁnding was obviously intriguing,
and soon led to the ‘‘caveolae signaling hypothesis”, i.e. to the idea
that caveolae, thanks to the presence of caveolins, may act as spe-
cialized plasma membrane structures able to assemble and coordi-
nate the functions of multiprotein complexes involved in signal
transduction, cellular trafﬁc, lipid homeostasis and cell adhesion
[4]. As much obviously, this shifted the focus from caveolae as
morphologically distinct organelles to caveolae as membrane areas
hallmarked by the presence of caveolins, going so far that shape
was no longer regarded by some Authors as essential in deﬁning
caveolae [21]. Experiments with knockout mice undoubtedly
revealed that caveolin-1 (that is ubiquitously expressed) and cave-
olin-3 (whose expression seems to be restricted in skeletal and
smooth muscle cells), but not caveolin-2, are necessary for the for-
mation of caveolae [22–24]. Caveolin expression in many cell types
corresponds to caveolae formation. Caveolae number and caveolin-
1 expression parallely increase during adypocyte differentiation,
and decrease upon oncogenic transformation of ﬁbroblasts [25].
Caveolin-1 transfection in cell lines (lymphocytes, Fischer rat thy-
roid cell) [26,27] lacking caveolin and caveolae resulted in the for-
mation of morphologically distinguishable caveolae. On the other
hand, the levels of caveolins do not necessarily correlate with cav-
eolae number when comparing different tissues expressing similar
amounts of caveolins [28], caveolin-1 is expressed in cells lacking
caveolae, such as hippocampal neurons [29] and leukocytes [30],
and caveolin-1 gene transfection does not induce the formation
of caveolae in the human prostate cancer cell line LNCaP [27].
These data suggest that, even if caveolin-1 seems an essential com-
ponent of caveolae, a substantial pool of caveolin can be present in
non-caveolar regions. Even in cells with caveolae, caveolins can be
found outside of caveolae (reviewed in [28]). Indeed, the presence
of caveolin-1 on the cytoplasmic face of caveolae has been ques-
tioned by the ﬁnding that caveolin-1 is rather present in intra-
membrane particles interacting with caveolae surface [31],caveolin-1 is also associated with many other intracellular loca-
tions, including the trans-Golgi network and other organelles
[32,33], and caveolin-1 antibodies also bind ﬂat membrane por-
tions [34]. Moreover, cytosolic pools of caveolin-1 complexed with
other proteins have been observed [35–37]. In MDCK cells, caveo-
lae are present only on the basolateral but not on the apical sur-
face. Caveolin-1 in these cells is present associated with caveolae
at the basolateral membrane, but it can be isolated as detergent-
insoluble, cholesterol-dependent complexes at the apical mem-
brane [38].
As mentioned above, the ‘‘caveolae signaling hypothesis” is
mainly based on the assumption that caveolin provides a molecu-
lar organizer for protein–protein interactions within caveolae. One
could argue that this should be rather referred to as ‘‘caveolin sig-
naling hypothesis”. The equation between caveolae and caveolin-
rich domains has been a tenet for many years, also because many
of the methods used to investigate caveolin- or caveolae-depen-
dent functions cannot discriminate between the two. However, a
critical reading of the literature allows to discriminate between a
group of functions that properly require the caveolar structure
(and, thus, caveolins as fundamental part of it) and a group of func-
tions that are more closely related to caveolins (not necessarily,
but in some cases probably, as part of the caveolae). Examples of
these functions are grouped in Table 1. In addition, some cell reg-
ulation phenomena can be surely ascribed to caveolins outside
caveolae (summarized in Table 2). Finally, a biological role of cave-
olin-2, the caveolin not required for caveolae formation, has re-
cently emerged.
3. Caveolae, caveolins and lipid rafts
One of the ﬁrst properties observed for caveolin-1 was its
insolubility in cold non-ionic detergents together with apical
markers in epithelial cells [32]. In the same year, Brown and Rose
[39] showed that glycosylphosphatidylinositol (GPI)-anchored
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epithelial cells can be isolated as low density, Triton X-100-insolu-
ble vesicles enriched in sphingolipids. This ﬁnding was in agree-
ment with a previous hypothesis from Simons and van Meer [40],
who postulated that glycolipids could organize structures in the
trans Golgi network (‘‘lipid rafts”) responsible for the sorting of api-
cal components in polarized epithelial cells. The conﬂuence of
experimental results coming from very heterogeneous research
areas ultimately led to a scenario in which ‘‘lipid rafts” or ‘‘sphingo-
lipid- and cholesterol-enriched membrane domains” are regarded
as membrane domains of deﬁned composition and speciﬁc func-
tion, including trafﬁc of cellular components and regulation of cell
signaling. This role clearly overlaps with that postulated for caveo-
lae in the ‘‘caveolae signaling hypothesis”, and it has been soon as-
sumed that caveolae and sphingolipid-enriched membrane
domains might represent specialized subsets of lipid rafts. How-
ever, the relationship between caveolae and lipid rafts is much
more complex, and several pieces of evidence suggest that caveolae
and sphingolipid-enriched membrane domains can exist
independently.
In all cell types so far investigated, cell sphingolipids, together
with cholesterol and saturated phosphatidylcholine, are associated
with a low-density membrane fraction that can be separated by
ultracentrifugation on density gradients from a cell lysate obtained
in the presence of Triton X-100 or other non-ionic detergents [41].
This fraction is usually regarded as a lipid raft-enriched fraction.
When this procedure has been applied to cells expressing caveo-
lins, caveolins have been found to be enriched into the same Tri-
ton-insoluble, low buoyancy membrane fractions ([42] and many
others), and these fractions have been regarded as isolated caveo-
lae fractions. However, a signiﬁcant portion of caveolin is also
recovered in the detergent-soluble fractions, and, on the other
hand, detergent-insoluble domains are also found in cells lacking
caveolin expression and caveolae structures, including leukocytes
and several neuronal cell types [43–49]. Fluorescence microscopy
and EM studies suggested that GPI-anchored, components of lipid
rafts, proteins are not constitutively concentrated in caveolae, but
are rather recruited to caveolae upon cross-linking-triggered clus-
tering [50]. An immunoseparated caveolae fraction from rat lung
vasculature was found to be devoid of several proteins usually re-
garded as lipid raft markers [51]. Epidermal growth factor receptor
(EGFR) is localized within a caveolin-rich fraction in A431 cells
[52]. However, EGFR-containing membrane fragments behaving
as classical lipid rafts (i.e., Triton X-100 insoluble, enriched in
GM1 ganglioside1 and sensitive to depletion of cholesterol
[53,54]) can be separated from caveolae [55,56]. Several papers
suggest a link between caveolae and/or caveolins and cholesterol,
one of the main lipids in lipid rafts. EM experiments with choles-
terol-binding probes showed that caveolae are enriched in choles-
terol [57]. Cholesterol is essential for caveolae formation and
maintenance [58], and caveolae structure is highly sensitive to
cholesterol depletion or treatment with cholesterol-binding drugs
[59]. Caveolin-1 tightly and speciﬁcally binds free cholesterol and
artiﬁcial cholesterol-containing vesicles [60–62]. Caveolin palmi-
toylation does not affect its association with lipid rafts, however
it is relevant for caveolin interaction with cholesterol [63]. Caveo-
lin gene transcription is regulated by LDL free cholesterol [64], and
caveolin oligomerization in cell membranes is affected by the cel-
lular cholesterol level [65]. In addition to cholesterol, detergent
resistant membrane preparations are also highly enriched in
sphingolipids, whose physico-chemical properties are supposed
to be relevant for the lateral interactions that stabilize lipid rafts1 Ganglioside and glycosphingolipid nomenclature is in accordance with the
IUPAC-IUBMB recommendations.[3]. However, in the case of sphingolipids, their presence in caveo-
lae is much less clear, and strongly controversial experimental
pieces of evidence can be found in the literature. Enrichment of
caveolae in neutral glycolipids and sphingomyelin has been shown
by EM immunogold labeling experiments using speciﬁc antibodies
[34,65], however, it has been suggested that caveolar localization
of neutral glycolipids and sphingomyelin only occurs after anti-
body crosslinking [34]. GM1 was detected by EM coupled with
cholera toxin labeling in a puriﬁed caveolar fraction prepared from
rat lung endothelium [66]. Cholera toxin B subunit, a component of
a heat-labile enterotoxin produced by Vibrio cholerae, is a useful
probe to detect GM1 ganglioside because of its high afﬁnity for this
glycolipid. Nevertheless, it is necessary to recall that cholera toxin
shows similar or higher afﬁnity toward other gangliosides such as
Fuc-GM1 [67,68]. In addition to this, glycoproteins can be also rec-
ognized [68]. The presence of sphingomyelin and ceramide was ob-
served in a Triton X-100 resistant caveolar fraction from human
ﬁbroblasts [69]. The analysis of a highly puriﬁed caveole fraction
from rat adipocytes showed that they are highly enriched in cho-
lesterol, sphingomyelin and GD3 ganglioside [70]. GM3 (by far
the major glycosphingolipid in these cells) and GM1 were enriched
at lesser extent in caveolae, but also present outside caveolae,
while caveolae were void of GM2, polisialogangliosides, sulfatide
and lactosylceramide sulfate, that represent minor components
in adipocytes but are very abundant in other cell types. GM3-en-
riched membrane domains from B16 melanoma (‘‘glycosynapses”)
and caveolae separated by immunoafﬁnity using anti-GM3 or anti-
caveolin antibodies [71] have different lipid composition. The
GM3-enriched membrane fraction contained GM3, sphingomyelin
and cholesterol. In contrast, the caveolar membrane fraction con-
tained glucosylceramide, a very large quantity of cholesterol and
only a small quantity of sphingomyelin, but did not contain GM3
[71]. This different lipid composition has a profound functional sig-
niﬁcance, as indicated by the fact that glycosynapse-dependent
biological events (e.g., GM3-dependent adhesion and consequent
c-Src and FAK activation in B16 melanoma cells) are not affected
by cholesterol-sequestering drugs. On the other hand they are dis-
rupted by compounds structurally related to GM3 [72].
These discrepancies obviously suggest that further investigation
is required to ascertain the presence and understand the role of
sphingolipids in caveolae, and that speciﬁc sphingolipids might
partition differentially between caveolae, lipid rafts and other
membrane areas. One possible explanation of these controversial
results derives from the prediction (based on model membranes)
that the segregation of glycosphingolipids would be favoured in
membrane regions with a strong positive curvature [73,74]. Based
on this, it can be hypothesized that the neck region of a caveola
could be highly enriched in glycosphingolipids, while its lumen
might be devoid of these lipids (Fig. 1). However, to test this
hypothesis it will be necessary to develop methods allowing a ﬁne
dissection of the caveolae and lipid raft structure, and the lipid
analysis of their composition with a very high sensitivity.4. Caveolin and sphingolipids
Several pieces of evidence indicated that caveolin-1 functions as
a molecular organizer for membrane multiprotein signaling com-
plexes. Caveolin-1 is typically associated with Triton-insoluble,
low buoyancy membrane fractions enriched in (glyco)sphingo-
lipids and cholesterol, even if, as mentioned above, caveolae and
non-caveolar lipid domains can exist independently in cells. The
complex supermolecular membrane organizations assembled by
caveolin-1 deﬁne highly specialized detergent-insoluble lipid
domains, possibly representing specialized forms or subsets of li-
pid raft or lipid-rich membrane domain.
Fig. 1. The ﬁne structure of caveolae. Caveolae are stabilized by a ﬁlamentous coat composed by caveolin oligomers. Caveolae are highly enriched in cholesterol. Different
sphingolipids has been shown to partition differentially between caveolae and non-caveolar membrane areas. Since the segregation of glycosphingolipids is favoured in
membrane regions with a strong positive curvature, it can be predicted that the ﬂask-shaped caveolae lumen should be relatively void of glycosphingolipids, while they might
be highly concentrated in the neck region of caveolae.
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interact with caveolin-1 via the caveolin scaffold domain. Caveo-
lin-1 seems to function as a versatile hydrophobic membrane
adapter. For example, it has been proposed that caveolin-1 might
functionally couple the integrin receptors with cytosolic Src-family
protein tyrosine kinases [75]. Non-receptor tyrosine kinases of the
Src family are involved in several cell functions such as mitogenic
response to growth factors, ﬁbroblasts cell migration and epithelia
cell scattering, and in cancer. Src kinases, located on the inner face
of membranes, are concentrated in the speciﬁc membrane domains
deﬁned by sphingolipids, and usually enriched in caveolin. Src-
family kinases, such as Fyn, Yes, Lck, Lyn are supposed to in lipid
rafts due to their dual acylation (myristoyl and palmitoyl residues)
[76]. However, c-Src, that has a single myristoyl residue, is also en-
riched in lipid rafts. The interaction of Src with caveolin is well-
established and has important consequences. More in general,
Src kinases localization in caveolin- and/or sphingolipid-enriched
domains seems to be instrumental for Src-dependent biological
events. In non-transformed cells, caveolin-1 is phosphorylated at
Tyr14 in response to growth factor signaling [77]. Caveolin-1 is
phosphorylated at Tyr14 under basal conditions in carcinoma cell
lines, but not in immortalized ovarian epithelial cells [78]. Src in-
duces phosphorylation of caveolin-1 at Tyr14, and this event is
responsible for the rearrangement of caveolin within the cell
[79–81]. Csk, the main negative regulator of c-Src and other related
kinases [82], is a cytosolic enzyme that may need an intermediary
protein to locate in Src kinases vicinity. Several candidates have
been described such as paxillin, Csk binding protein/phosphopro-
tein associated with glycosphingolipids (PAG), and caveolin-1.
Caveolin-1 phosphorylation is in turn involved in the regulation
of the docking of Csk, the negative regulator of Src, suggesting amechanism of negative regulation of Src activity by phosphory-
lated caveolin [83]. Moreover, phosphorylated caveolin is recruited
to lipid-enriched membrane domains upon integrin receptor dis-
engagement, favoring the internalization of these specialized
membrane areas and inhibiting the signalling events downstream
to integrin receptor [84].
The question is, whether signaling complexes organized by
caveolins can be controlled in their function by the composition
of their sphingolipid-rich membrane environment, and/or by spe-
ciﬁc interactions of caveolin with sphingolipids. Several pieces of
evidence indicate that caveolin-1 and sphingolipid organizations
within the membrane are interdependent. HPV-16 E5 oncoproteins
parallel upregulated caveolin-1 expression and GM1 content, and
increases GM1/caveolin-1 association in cervical cells [85]. In a
UDP-Gal-4-epimerase deﬁcient cell line, it has been shown that
caveolin-1 is localized in lipid rafts when GM3 synthesis is blocked
by removing galactose from the culture medium, but it is relocated
outside glycolipid-enriched membrane fractions when GM3
synthesis occurs [86]. In a keratinocyte-derived cell line, GM3
overexpression induced a shift of caveolin-1 to detergent-soluble
membrane regions, allowing its functional interaction with the
EGFR receptor, that caused inhibition of EGFR tyrosine phosphory-
lation and dimerization [87]. On the other hand, EGFR signaling in
a squamous carcinoma cell line requires both GM3 and caveolin-1
[88]. In mouse osteosarcoma cells, GD1a content regulates caveo-
lin-1 expression [89]. Insulin receptors (IR) are present in deter-
gent-resistant membranes from normal adipocytes [90] and
localized in caveolae in intact cells [91], where the b-subunit of
IR interacts with caveolin-1 through a binding motif recognizing
the scaffold domain of caveolin-1 [92]. This interaction is essential
for insulin signaling, as conﬁrmed by the observation that caveo-
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high-fat diet [93]. In 3T3-L1 adipocytes, the induction of insulin
resistance by treatment with tumor necrosis factor alpha was
accompanied by the upregulation of GM3 synthase, leading to an
increase of cellular GM3 [91,94], that accumulated in detergent-
resistant membranes. The excess amount of GM3 in lipid rafts
led to the displacement of IR from the complex with caveolin-1,
thus suggesting that the regulation of IR/caveolin-1 by GM3 could
be responsible for the changes in insulin response in adipocytes
[95]. A similar regulatory mechanism has been recently observed
for platelet-derived growth factor receptor (PDGFR) [96]. Overex-
pression of the N-terminal domain of PAG, caused the accumula-
tion of GM1 at the cell surface (evaluated by cholera toxin
labeling and immunoﬂuorescence microscopy, with the above
mentioned caveats on the use of this probe), with the consequent
displacement of PDGFR from caveolin-rich fractions and caveolae,
without altering the caveolar distribution of caveolin-1. The same
redistribution of PDGFR has been observed after incubation of cells
with exogenous GM1. Remarkably, the plasma-membrane-associ-
ated sialidase Neu3, able to modify the cell surface ganglioside
composition, is associated with Triton X-100 insoluble glycosphin-
golipid-enriched membranes [97], and closely interacting with
caveolin-1 in Neu3-transfected COS-1 cells [98]. Caveolin-1 associ-
ation with lipid rafts and caveolin-dependent signaling seem to be
also sensitive to the cellular levels of ceramide [99]. In fact, it has
been suggested that increased ceramide production upon different
stimuli might displace caveolin-1 from sphingolipid- and choles-
terol-rich membrane complexes [100]. Usually the production of
bioactive ceramide is ascribed to sphingomyelin hydrolysis by
sphingomyelinases, and these enzymes have been found in lipid
rafts, where in some cases they have been reported to interact with
caveolin-1 [101].
On the other hand, caveolin-1 overexpression in human
melanoma cells caused a marked dispersion of GD3 outside the
detergent-insoluble fraction (without affecting the cellular glyco-
sphingolipid composition), that corresponded to a deep disorgani-
zation of the leading edges [102].
All these data suggest that caveolin-1 and sphingolipid levels in
lipid rafts are concomitantly and reciprocally regulated, and that
caveolin-1-rich and sphingolipid-rich membrane microenviron-
ment are dynamically interacting.
In addition, a few papers describe direct interactions between
caveolin-1 and sphingolipids. The paucity of information in this re-
gard is in large part due to the lack of versatile tools for the study of
sphingolipid–protein interactions. Caveolin-1 has been shown to
bind exogenously added photoreactive derivatives of GM1 and
GM3 in A431 and MDCK cells [103,104], even if kinetic studies
showed that the interaction between GM3 and caveolin-1 is a tran-Fig. 2. The EGFR/GM3/caveolin-1/CD82. Caveolin-1 and GM3 are simultaneously (togeth
signaling in human squamous carcinoma cells in non-caveolae membrane regions. In
caveolin-1 with the receptor requires the presence of both GM3 and CD82.sient process and EM experiments showed that in these cells cave-
olin-1 and GM3 are not localized in the same domain at the steady
state [103]. This could be explained by a redistribution of the
photoactivable ganglioside within the membrane. A direct
interaction between caveolin-1 and sphingomyelin has been
demonstrated using a photoactivable sphingolipid derivative syn-
thesized by cells in situ [105]. A direct interaction between GM3
and IR involving a speciﬁc lysine residue of the receptor has been
described [95].
5. Regulation of caveolin-dependent signaling complexes by
glycosphingolipids
As discussed in the previous section, the caveolin-1 and sphin-
golipid-rich membrane complexes are dynamically interacting and
interdependent in their compositional regulation. So far, at least
two different mechanisms can be hypothesized to explain the
effects of glycosphingolipids on signaling complexes organized
by caveolin-1: (1) both caveolin-1 and glycosphingolipids are
simultaneously required in some cases to organize the molecular
architecture of a signaling complex. This seems the case for EGFR:
for this receptor the formation of a signaling complex with caveo-
lin-1, tetraspanin CD82 and GM3 ganglioside (probably in non-
caveolar membrane regions) allows the interaction of EGFR with
activated PKC-A, ultimately leading to the inhibition of EGFR sig-
naling [53–56,88] (Fig. 2). However, this signaling complex does
not seem to require a direct caveolin–GM3 interaction [88]. (2)
In other cases, caveolin-1 and sphingolipids can compete for a
common interactor. This is exempliﬁed by IR (Fig. 3), that can form
a complex with caveolin-1 (probably in caveolae) required for
insulin signaling leading to the translocation of GLUT4 at the sur-
face of normal adipocytes [91]. Accumulation of GM3 upon acqui-
sition of insulin resistance lead to the displacement of IR from the
caveolin-1 complex and its sequestration as a complex with GM3
[95]. In this case it has been convincingly demonstrated that a di-
rect GM3–IR interaction is required. Increased GM1 cellular levels
lead to the displacement of another growth factor receptor, PDGF
(Fig. 4), from caveolae [96], negatively regulating Src mitogenic sig-
naling. However, in this case it is not knownwhether the formation
of a PDGFR–GM1 complex is required for its uncoupling from cav-
eolae. Since caveolin-1 can direct bind sphingolipids, including
GM1, in this case it cannot be excluded that GM1 forms a complex
with caveolin-1, or that an enrichment in GM1 inside the caveola
induces a deep reorganization of caveolar membrane, thus exclud-
ing PDGFR from caveolae.
The examples reported above illustrate how caveolin-1 and
glycosphingolipids could cooperate or compete in the multimolec-
ular organization of a membrane receptor with its interactors, thuser with CD82) to organize a signaling complex responsible for the inhibition of EGFR
this complex, GM3 and caveolin-1 do not directly interact, but the interaction of
Fig. 3. Competition of caveolin-1 and glycosphingolipids for shared interactors: IR. IR can form separate complex with caveolin-1 and GM3. High levels of GM3 in insulin-
resistant adipocytes result in the displacement of IR from the caveolin-1 complex, uncoupling it from the downstream signaling cascade.
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stream signaling events and regulating the receptor activity. An-
other way to regulate receptor function that can be inﬂuenced by
both caveolin and sphingolipids is represented by the downregula-
tion of plasma membrane receptor concentration through its inter-
nalization. The internalization of plasma membrane components,
including basal state, ligand-activated or transactivated receptors,
can exploit different routes whose complexity has been only re-
cently and partially unveiled. This usually leads to important con-
sequences for the receptor activity, encompassing its sequestration
in intracellular sites, recycling to the plasmamembrane, intracellu-
lar degradation or translocation to the nucleus. Internalization of
receptors occurs via clathrin-dependent and clathrin-independent
pathways [106]. Both mechanisms are involved in the removal of
receptor tyrosine kinases RTK (including whose RTK that areknown to be regulated by glycosphingolipids, such as EGFR, nerve
growth factor receptors, IR and PDGFR) from the plasma mem-
brane upon ligand activation. Clathrin-dependent endocytosis rep-
resents a single trafﬁc pathway well characterized in its steps and
molecular aspects. On the other hand, clathrin-independent endo-
cytosis encompasses several different pathways that are much
more poorly understood in their molecular mechanisms and phys-
iological signiﬁcance. Among those, caveolin-1-dependent, choles-
terol-sensitive endocytic mechanism are usually referred to as
‘‘caveolar endocytosis”. Caveolar endocytosis is dependent not only
on caveolin-1, but also on caveolae, and endothelial caveolae con-
tain the whole array of molecular components for a vesicular
transport system [107]. Lipid raft-dependent (cholesterol- and
sphingolipid-sensitive) but caveolin-1-independent internalization
pathways have also been described. The picture is still fragmen-
Fig. 4. Competition of caveolin-1 and glycosphingolipids for shared interactors: PDGF. Increased GM1 plasma membrane levels due to the expression of the N-terminal
domain of PAG, or exogenous GM1 administration lead to the displacement of PDGFR from caveolae, negatively regulating downstream mitogenic signaling. In the presence
of high GM1, a displacement of the receptor could be due to the competition of GM1 and caveolin-1 for the binding with the receptor, or to the competition between GM1 and
PDGFR for the formation of a complex with caveolin-1. The ﬁrst hypothesis implies the formation of independent PDGFR–caveolin-1 and PDGFR–GM1 complexes, the second
implies the existence of PDGFR–caveolin-1 and GM1–caveolin-1 separate complexes.
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dent endocytosis are similar but distinct processes, that are inter-
dependent and reciprocally regulated [6,16]. The situation is made
even more complex by two relevant observations: (1) association
of a molecule with lipid rafts/caveolae does not necessary implies
its internalization via a caveolae/lipid raft-mediated pathway. Mul-
tiple endocytic pathways have been described for the internaliza-
tion of lipid raft markers, as well exempliﬁed by the case of
cholera toxin, that can be internalized via caveolae but also via cav-
eolae/raft-independent mechanisms, including clathrin-dependent
endocytosis, despite its initial binding to GM1 within lipid rafts
[108–110]; (2) usually the internalization of lipid raft components
(such as RTK) via the clathrin-mediated mechanism requires that
they move outside caveolae/lipid raft compartment. However, in
some cases (e.g., EGFR), lipid raft recruitment is an essential prere-
quisite for clathrin-dependent endocytosis, indicating that the
association with lipid rafts can modulate as well lipid raft-indepen-
dent internalization mechanisms [111,112].
Under basal conditions, caveolae are relatively immobile struc-
tures with a low turnover at the plasma membrane levels [113],and are thus probably not heavily involved in constitutive endo-
cytic trafﬁcking. However, caveolae (and caveolin) can be mobi-
lized and internalized upon speciﬁc stimuli (e.g., antibody-
mediated cross-linking of GPI-anchored alkaline phosphatase
[114] and of major histocompatibility complex class I [115], cell
membrane attachment of SV40 virus [116], disengagement of inte-
grin receptors upon cell detachment [117]). Based on the observa-
tions that the loss of caveolae does not impair endocytosis of some
lipid raft markers [118,119] and that caveolin-1 levels inversely
correlate with the uptake of raft-associated receptors (e.g., reduc-
tion of caveolin levels accelerate raft-mediated internalization of
autocrine motility factor receptor [120], it has been proposed that
caveolin-1 could indeed act as a negative regulator of caveolae/
raft-mediated receptor uptake, stabilizing and immobilizing
potentially endocytic raft domains [6,16]. Triggering of caveolae/
raft-mediated internalization would thus require additional factors
allowing to overcome to restraint to endocytosis imposed by cave-
olin-1. It has been shown that caveolae/rafts internalization in re-
sponse to speciﬁc stimuli is dependent on glycosphingolipids and
tyrosine phosphorylation. Sphingolipids are essential for clathrin-
604 S. Sonnino, A. Prinetti / FEBS Letters 583 (2009) 597–606independent endocytosis [121], and glycosphingolipids stimulate
caveolar endocytosis [122,123]. Glycosphingolipids could directly
affect the membrane environment of caveolin-1 (via direct interac-
tions with caveolin-1 or altering the packing of cholesterol in cave-
olin-1 rich membrane domains), or could regulate tyrosine
phosphorylation of caveolin-1, that is an essential requirement
for caveolar/raft endocytosis [84]. Indeed, using ﬂuorescent sphin-
golipid analogues it has been proven that sphingolipid segregation
in endocytic vesicles is essential for caveolar endocytosis. On the
other hand, glycosphingolipid-stimulated caveolar endocytosis re-
quired Src activity, and addition of exogenous sphingolipids or
cholesterol has been shown to stimulate Src activity [124]. Thus,
likely multiple mechanisms regulated by sphingolipids are poten-
tially responsible for triggering caveolar endocytosis.
Along this line, another mechanism that could be involved in
glycosphingolipid-regulated and caveolin-mediated clearance of
plasma membrane receptors is suggested by the observation that
many RTK (including EGFR, PDGFR and IR) are at least in part local-
ized in lipid rafts, have a caveolin binding motive and form com-
plexes with caveolin-1, as discussed above. In all these cases, the
elevation of cellular ganglioside levels has as a consequence the
shift of the receptor outside of caveolae [125]. In the case of IR
and PDGFR, this resulted in the uncoupling of the receptor from
the downstream signaling cascade. However, as mentioned above,
movement of RTK outside caveolar membrane domains potentially
target these receptors to clathrin-dependent internalization path-
ways, thus contributing in the negative regulation of cell surface
concentration of the receptor.
6. Conclusions
All together, these pieces of evidence suggest that caveolin-1
can organize multiple and heterogeneous multimolecular com-
plexes, whose structure and function is not exclusively related to
caveolae. On the other hand, in many cases caveolin-1 and sphin-
golipids seem to be part of an integrated network of interactions
in cell membranes, that can signiﬁcantly contribute to the regula-
tion of cellular function, through the regulation of the functional
activity and plasma membrane concentration of several receptor
molecules. The molecular organization and regulation of these
complexes remains in most cases to be further elucidated. Novel
knowledge on this topic will probably shed a new light on caveo-
lin- and sphingolipid-mediated biological events, and will contrib-
ute in redeﬁning the notion of caveolar and sphingolipid-enriched
membrane domains and of their role in cell signaling and trafﬁc.
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